[HTML][HTML] Targeting autophagy to overcome drug resistance: further developments

H Chang, Z Zou - Journal of hematology & oncology, 2020 - Springer
Inhibiting cell survival and inducing cell death are the main approaches of tumor therapy.
Autophagy plays an important role on intracellular metabolic homeostasis by eliminating …

Role and mechanism of autophagy‐regulating factors in tumorigenesis and drug resistance

RM Usman, F Razzaq, A Akbar… - Asia‐Pacific Journal …, 2021 - Wiley Online Library
A hallmark feature of tumorigenesis is uncontrolled cell division. Autophagy is regulated by
more than 30 genes and it is one of several mechanisms by which cells maintain …

[HTML][HTML] Extracellular HMGB1 blockade inhibits tumor growth through profoundly remodeling immune microenvironment and enhances checkpoint inhibitor-based …

P Hubert, P Roncarati, S Demoulin… - … for immunotherapy of …, 2021 - ncbi.nlm.nih.gov
Background High-mobility group box 1 (HMGB1) is a multifunctional redox-sensitive protein
involved in various intracellular (eg, chromatin remodeling, transcription, autophagy) and …

[HTML][HTML] Damage-associated molecular patterns (DAMPs) related to immunogenic cell death are differentially triggered by clinically relevant chemotherapeutics in lung …

JIG Solari, E Filippi-Chiela, ES Pilar, V Nunes… - BMC cancer, 2020 - Springer
Background Chemotherapeutics can stimulate immune antitumor response by inducing
immunogenic cell death (ICD), which is activated by Damage-Associated Molecular Patterns …

[HTML][HTML] Down-regulation of LncRNA TUG1 enhances radiosensitivity in bladder cancer via suppressing HMGB1 expression

H Jiang, X Hu, H Zhang, W Li - Radiation Oncology, 2017 - Springer
Abstract Background Long non-coding RNAs (lncRNAs) have been reported to regulate the
sensitivity of different cancer cells to chemoradiotherapy. Aberrant expression of lncRNA …

circ _0007385 served as competing endogenous RNA for miR‐519d‐3p to suppress malignant behaviors and cisplatin resistance of non‐small cell lung cancer cells

Y Ye, L Zhao, Q Li, C Xi, Y Li, Z Li - Thoracic cancer, 2020 - Wiley Online Library
Background Circular RNAs (circRNAs) have been closely implicated in competing
endogenous RNA (ceRNA) network among human cancers including non‐small cell lung …

High cytotoxicity of vanadium (IV) complexes with 1, 10-phenanthroline and related ligands is due to decomposition in cell culture medium

M Le, O Rathje, A Levina, PA Lay - JBIC Journal of Biological Inorganic …, 2017 - Springer
Cytotoxic effects of Metvan (cis-[V IV O (OSO 3)(Me 2 phen) 2], where Me 2 phen= 4, 7-
dimethyl-1, 10-phenanthroline) and its analogues with 1, 10-phenanthroline (phen) and 2 …

Effect of chemotherapeutics on in vitro immune checkpoint expression in non-small cell lung cancer

Y Zhao, Z Wang, X Shi, T Liu, W Yu… - … in Cancer Research …, 2023 - journals.sagepub.com
Objectives: Immune checkpoint (ICP) expression in tumor cells could directly or indirectly
affect the results of immunotherapy. ICP ligands on tumor cells usually bind their immune …

Targeting ROS-AMPK pathway by multiaction Platinum (IV) prodrugs containing hypolipidemic drug bezafibrate

X Qiao, YY Gao, LX Zheng, XJ Ding, LW Xu… - European Journal of …, 2021 - Elsevier
Alterations in lipid metabolism, commonly disregarded in the past, have been accepted as a
hallmark for cancer. Exploring cancer therapeutics that interrupt the lipid metabolic pathways …

HMGB1 release promotes paclitaxel resistance in castration-resistant prostate cancer cells via activating c-Myc expression

X Lei, X Hu, T Zhang, J Zhang, C Wu, W Hong, Y Jiang… - Cellular …, 2020 - Elsevier
Paclitaxel (PTX) is one of standard chemotherapy drug for patients with metastatic castration-
resistant prostate cancer (mCRPC). However, PTX resistance leads to treatment failures, for …